Big Pharma is also showing interest for this emerging market and an example which illustrates this attention is the deal that Merck KGaA has just signed with Chi-Med under which the German drugmaker will develop new cancer treatments using traditional Chi
Despite 15 years as a cancer doctor and researcher, I struggle several times each week to endure the hardest part of my job – walking into a patient's room to helplessly watch as cancer steals away their life and torments them and their loved ones...we